Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-14

Clinical Trial Update: Pregabalin Trial for the Treatment of Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of pregabalin for Alcohol Use Disorder has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alcohol Use Disorder | Phase 2 | Status: SUSPENDED